Small textMedium textLarge text   Galderma UK
Home
About Galderma UK
Our History
News
Financial Sponsorship
Contact Information
Wholesale terms & conditions
Conditions We Treat
Our Products
Manufacturing
R&D
Working at Galderma
Contact Us
For Professionals

For ProfessionalsResources for today's healthcare professionals.
> More

News

Galderma completes acquisition of Collagenex
Friday, April 11, 2008

Galderma Pharma S.A., a global specialty pharmaceutical company focused on dermatology, today announced that its U.S. holding company, Galderma Laboratories, Inc., has completed its acquisition of CollaGenex Pharmaceuticals, Inc. (NASDAQ: CGPI). 

More...

Galderma completes tender offer for Collagenex
Monday, April 07, 2008

Galderma Pharma S.A., a global specialty pharmaceutical company focused on dermatology, today announced that its U.S. holding company, Galderma Laboratories, Inc., has completed its all cash tender offer for CollaGenex Pharmaceuticals, Inc. (NASDAQ: CGPI).

More...

Galderma reaches agreement to acquire Collagenex Pharmaceuticals
Tuesday, February 26, 2008

Galderma Pharma S.A., a global specialty pharmaceutical company focused on dermatology, and CollaGenex Pharmaceuticals, Inc. (NASDAQ: CGPI) today announced a definitive agreement pursuant to which Galderma’s U.S. holding company, Galderma Laboratories, Inc., will acquire all of the outstanding shares of CollaGenex at a price of $16.60 per share in cash, representing approximately $420 million for the equity of CollaGenex.

More...
     
We use cookies to ensure that we give you the best experience on our website.
For more information on which cookies are set when visiting this site and how to manage cookies on your computer/device please visit our cookie policy. By continuing to use this site, you agree to the use of cookies as outlined in our cookie policy and privacy policy. Click continue to close.